# Yersinia Pestis Lateral Flow Immunoassay for Blood Samples

> **NCT04688996** · — · UNKNOWN · sponsor: **Brimrose Technology Corporation** · enrollment: 500 (estimated)

## Conditions studied

- Plague
- Plague, Bubonic
- Plague, Pneumonic
- Yersinia Pestis Plague
- Yersinia Pestis; Bubo
- Yersinia Pestis; Pneumonia
- Yersinia Sepsis
- Yersinia Pestis Infection
- Bubo; Yersinia Pestis
- Bubonic; Plague, Skin
- Pneumonic Plague

## Interventions

- **DIAGNOSTIC_TEST:** Lateral Flow Assay for Pathogens of the Plague

## Key facts

- **NCT ID:** NCT04688996
- **Lead sponsor:** Brimrose Technology Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-19
- **Primary completion:** 2022-12
- **Final completion:** 2023-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-12-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04688996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04688996, "Yersinia Pestis Lateral Flow Immunoassay for Blood Samples". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04688996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*